Abstract
Dystonia is a multifaceted movement disorder causing a range of types of involuntary movement. Two axes are used to distinguish different subtypes of dystonia: clinical aspects (time of onset and distribution of symptoms) and etiology (e.g., primary vs. secondary). Patients who are not adequately treated with medical therapy are referred for surgical treatment, which primarily consists of deep brain stimulation. The pallidum is the most common target for treatment of dystonia and has been shown to be effective for the heterogenous group of dystonia disorders. Other deep brain stimulation targets can also be considered. Deep brain stimulation can be performed using a variety of techniques, both awake and asleep, both with and without microelectrode recording, with a frame and frameless, and with a variety of image-guided approaches. There are some special considerations for dystonia patients that should be considered when determining the appropriate surgical treatment. New techniques for ablation have reintroduced pallidotomy as a potential surgical treatment in select cases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Steeves TD, et al. The prevalence of primary dystonia: a systematic review and meta-analysis. Mov Disord. 2012;27(14):1789–96.
Albanese A. How many Dystonias? Clinical evidence. Front Neurol. 2017;8:18.
Pirio Richardson S, et al. Research priorities in limb and task-specific Dystonias. Front Neurol. 2017;8:170.
Marsden CD. Dystonia: the spectrum of the disease. Res Publ Assoc Res Nerv Ment Dis. 1976;55:351–67.
Albanese A, et al. Phenomenology and classification of dystonia: a consensus update. Mov Disord. 2013;28(7):863–73.
Morgan VL, Rogers BP, Abou-Khalil B. Segmentation of the thalamus based on BOLD frequencies affected in temporal lobe epilepsy. Epilepsia. 2015;56(11):1819–27.
Morgante F, Klein C. Dystonia. Continuum (Minneap Minn). 2013;19(5 Movement Disorders):1225–41.
Torres-Russotto D, Perlmutter JS. Task-specific dystonias: a review. Ann N Y Acad Sci. 2008;1142:179–99.
Frucht SJ, et al. The natural history of embouchure dystonia. Mov Disord. 2001;16(5):899–906.
Sitburana O, et al. Motor overflow and mirror dystonia. Parkinsonism Relat Disord. 2009;15(10):758–61.
Patel N, et al. Alleviating manoeuvres (sensory tricks) in cervical dystonia. J Neurol Neurosurg Psychiatry. 2014;85(8):882–4.
Broussolle E, et al. Early illustrations of Geste Antagoniste in cervical and generalized dystonia. Tremor Other Hyperkinet Mov (N Y). 2015;5:332.
Lee CN, et al. “Visual sensory trick” in patient with cervical dystonia. Neurol Sci. 2012;33(3):665–7.
Stojanovic M, et al. Improvement in laryngeal dystonia with background noise. Mov Disord. 1997;12(2):249–50.
Asmus F, et al. Reverse sensory geste in cervical dystonia. Mov Disord. 2009;24(2):297–300.
Greene PE, Bressman S. Exteroceptive and interoceptive stimuli in dystonia. Mov Disord. 1998;13(3):549–51.
Ozelius L, et al. Human gene for torsion dystonia located on chromosome 9q32-q34. Neuron. 1989;2(5):1427–34.
Klein C. Genetics in dystonia. Parkinsonism Relat Disord. 2014;20(Suppl 1):S137–42.
Phukan J, et al. Primary dystonia and dystonia-plus syndromes: clinical characteristics, diagnosis, and pathogenesis. Lancet Neurol. 2011;10(12):1074–85.
Hawker K, Lang AE. Hypoxic-ischemic damage of the basal ganglia. Case reports and a review of the literature. Mov Disord. 1990;5(3):219–24.
Lee MS, Marsden CD. Movement disorders following lesions of the thalamus or subthalamic region. Mov Disord. 1994;9(5):493–507.
Burke RE, Fahn S, Gold AP. Delayed-onset dystonia in patients with “static” encephalopathy. J Neurol Neurosurg Psychiatry. 1980;43(9):789–97.
Hilaire MHS, et al. Delayed-onset dystonia due to perinatal or early childhood asphyxia. Neurology. 1991;41(2, Part 1):216.
Zadori D, et al. Drug-induced movement disorders. Expert Opin Drug Saf. 2015;14(6):877–90.
Jankovic J, et al. Relationship between various clinical outcome assessments in patients with blepharospasm. Mov Disord. 2009;24(3):407–13.
Consky E, Lang A. Clinical assessments of patients with cervical dystonia. In: Jankovic J, Hallett M, editors. Therapy with botulinum toxin. New York: Marcel Dekker; 1994. p. 211–37.
Muller J, et al. Craniocervical dystonia questionnaire (CDQ-24): development and validation of a disease-specific quality of life instrument. J Neurol Neurosurg Psychiatry. 2004;75(5):749–53.
Comella CL, et al. Rating scales for dystonia: a multicenter assessment. Mov Disord. 2003;18(3):303–12.
Krystkowiak P, et al. Reliability of the Burke-Fahn-Marsden scale in a multicenter trial for dystonia. Mov Disord. 2007;22(5):685–9.
Burke RE, et al. Validity and reliability of a rating scale for the primary torsion dystonias. Neurology. 1985;35(1):73–7.
Jankovic J. Medical treatment of dystonia. Mov Disord. 2013;28(7):1001–12.
Albanese A, et al. EFNS guidelines on diagnosis and treatment of primary dystonias. Eur J Neurol. 2011;18(1):5–18.
Delnooz CC, et al. Paramedical treatment in primary dystonia: a systematic review. Mov Disord. 2009;24(15):2187–98.
De Pauw J, et al. The effectiveness of physiotherapy for cervical dystonia: a systematic literature review. J Neurol. 2014;261(10):1857–65.
Tassorelli C, et al. Botulinum toxin and neuromotor rehabilitation: an integrated approach to idiopathic cervical dystonia. Mov Disord. 2006;21(12):2240–3.
Nygaard TG, Marsden CD, Duvoisin RC. Dopa-responsive dystonia. Adv Neurol. 1988;50:377–84.
Segawa M, et al. Hereditary progressive dystonia with marked diurnal fluctuation. Adv Neurol. 1976;14:215–33.
Karp BI, et al. An open trial of clozapine for dystonia. Mov Disord. 1999;14(4):652–7.
Jankovic J. Tardive syndromes and other drug-induced movement disorders. Clin Neuropharmacol. 1995;18(3):197–214.
Shapleske J, Mickay AP, McKenna PJ. Successful treatment of tardive dystonia with clozapine and clonazepam. Br J Psychiatry. 1996;168(4):516–8.
Simpson GM. The treatment of tardive dyskinesia and tardive dystonia. J Clin Psychiatry. 2000;61(Suppl 4):39–44.
Jankovic J, Beach J. Long-term effects of tetrabenazine in hyperkinetic movement disorders. Neurology. 1997;48(2):358–62.
Chen JJ, et al. Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature. Clin Ther. 2012;34(7):1487–504.
Jankovic J. Treatment of hyperkinetic movement disorders with tetrabenazine: a double-blind crossover study. Ann Neurol. 1982;11(1):41–7.
Jankovic J, Orman J. Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias. Neurology. 1988;38(3):391–4.
Boyer WF, Bakalar NH, Lake CR. Anticholinergic prophylaxis of acute haloperidol-induced acute dystonic reactions. J Clin Psychopharmacol. 1987;7(3):164–6.
Holloman LC, Marder SR. Management of acute extrapyramidal effects induced by antipsychotic drugs. Am J Health Syst Pharm. 1997;54(21):2461–77.
Stern TA, Anderson WH. Benztropine prophylaxis of dystonic reactions. Psychopharmacology (Berl). 1979;61(3):261–2.
Fahn S. High dosage anticholinergic therapy in dystonia. Neurology. 1983;33(10):1255–61.
Albanese A, et al. A systematic review on the diagnosis and treatment of primary (idiopathic) dystonia and dystonia plus syndromes: report of an EFNS/MDS-ES Task Force. Eur J Neurol. 2006;13(5):433–44.
Burke RE, Fahn S, Marsden CD. Torsion dystonia: a double-blind, prospective trial of high-dosage trihexyphenidyl. Neurology. 1986;36(2):160–4.
Sanger TD, et al. Prospective open-label clinical trial of trihexyphenidyl in children with secondary dystonia due to cerebral palsy. J Child Neurol. 2007;22(5):530–7.
van den Heuvel CNAM, et al. The symptomatic treatment of acquired dystonia: a systematic review. Mov Disord Clin Pract. 2016;3(6):548–58.
Brans JW, et al. Botulinum toxin versus trihexyphenidyl in cervical dystonia: a prospective, randomized, double-blind controlled trial. Neurology. 1996;46(4):1066–72.
Hallett M, et al. Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders. Toxicon. 2013;67:94–114.
Simpson DM, et al. Practice guideline update summary: botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: report of the guideline development Subcommittee of the American Academy of Neurology. Neurology. 2016;86(19):1818–26.
Simpson DM, et al. Assessment: botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the therapeutics and technology assessment Subcommittee of the American Academy of Neurology. Neurology. 2008;70(19):1699–706.
Kruisdijk JJ, et al. Botulinum toxin for writer’s cramp: a randomised, placebo-controlled trial and 1-year follow-up. J Neurol Neurosurg Psychiatry. 2007;78(3):264–70.
Bentivoglio AR, et al. Fifteen-year experience in treating blepharospasm with Botox or Dysport: same toxin, two drugs. Neurotox Res. 2009;15(3):224–31.
Truong D, et al. Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study. Mov Disord. 2005;20(7):783–91.
Albavera-Hernandez C, Rodriguez JM, Idrovo AJ. Safety of botulinum toxin type A among children with spasticity secondary to cerebral palsy: a systematic review of randomized clinical trials. Clin Rehabil. 2009;23(5):394–407.
Pappert EJ, Germanson T. And G. Myobloc/Neurobloc European Cervical Dystonia Study, botulinum toxin type B vs. type A in toxin-naive patients with cervical dystonia: randomized, double-blind, noninferiority trial. Mov Disord. 2008;23(4):510–7.
Duarte GS, et al. Botulinum toxin type A versus botulinum toxin type B for cervical dystonia. Cochrane Database Syst Rev. 2016;10:CD004314.
Cooper IS. Clinical and physiologic implications of thalamic surgery for disorders of sensory communication. 2. Intention tremor, dystonia, Wilson’s disease and torticollis. J Neurol Sci. 1965;2(6):520–53.
Cooper IS. 20-year followup study of the neurosurgical treatment of dystonia musculorum deformans. Adv Neurol. 1976;14:423–52.
Gildenberg PL. Evolution of basal ganglia surgery for movement disorders. Stereotact Funct Neurosurg. 2006;84(4):131–5.
Cif L, Hariz M. Seventy years with the globus pallidus: Pallidal surgery for movement disorders between 1947 and 2017. Mov Disord. 2017;32:972.
Pretto TE, et al. A prospective blinded evaluation of deep brain stimulation for the treatment of secondary dystonia and primary torticollis syndromes. J Neurosurg. 2008;109(3):405–9.
Damier P, et al. Bilateral deep brain stimulation of the globus pallidus to treat tardive dyskinesia. Arch Gen Psychiatry. 2007;64(2):170–6.
Kiss ZH, et al. The Canadian multicentre study of deep brain stimulation for cervical dystonia. Brain. 2007;130(Pt 11):2879–86.
Diamond A, et al. Globus pallidus deep brain stimulation in dystonia. Mov Disord. 2006;21(5):692–5.
Vidailhet M, et al. Bilateral deep-brain stimulation of the globus pallidus in primary generalized dystonia. N Engl J Med. 2005;352(5):459–67.
Kupsch A, et al. Pallidal deep-brain stimulation in primary generalized or segmental dystonia. N Engl J Med. 2006;355(19):1978–90.
Moro E, et al. Efficacy of pallidal stimulation in isolated dystonia: a systematic review and meta-analysis. Eur J Neurol. 2017;24(4):552–60.
Romito LM, et al. Fixed dystonia unresponsive to pallidal stimulation improved by motor cortex stimulation. Neurology. 2007;68(11):875–6.
Sun B, et al. Subthalamic nucleus stimulation for primary dystonia and tardive dystonia. Acta Neurochir Suppl. 2007;97(Pt 2):207–14.
Woehrle JC, et al. Chronic deep brain stimulation for segmental dystonia. Stereotact Funct Neurosurg. 2009;87(6):379–84.
Racette BA, et al. Thalamic stimulation for primary writing tremor. J Neurol. 2001;248(5):380–2.
Minguez-Castellanos A, et al. Primary writing tremor treated by chronic thalamic stimulation. Mov Disord. 1999;14(6):1030–3.
Kuncel AM, et al. Myoclonus and tremor response to thalamic deep brain stimulation parameters in a patient with inherited myoclonus-dystonia syndrome. Clin Neurol Neurosurg. 2009;111(3):303–6.
Hedera P, et al. Surgical targets for dystonic tremor: considerations between the globus pallidus and ventral intermediate thalamic nucleus. Parkinsonism Relat Disord. 2013;19(7):684–6.
Morishita T, et al. Should we consider vim thalamic deep brain stimulation for select cases of severe refractory dystonic tremor. Stereotact Funct Neurosurg. 2010;88(2):98–104.
Fasano A, Bove F, Lang AE. The treatment of dystonic tremor: a systematic review. J Neurol Neurosurg Psychiatry. 2014;85(7):759–69.
Vercueil L, et al. Deep brain stimulation in the treatment of severe dystonia. J Neurol. 2001;248(8):695–700.
Ostrem JL, et al. Subthalamic nucleus deep brain stimulation in isolated dystonia: a 3-year follow-up study. Neurology. 2017;88(1):25–35.
Kramer DR, et al. Best surgical practices: a stepwise approach to the University of Pennsylvania deep brain stimulation protocol. Neurosurg Focus. 2010;29(2):E3.
Machado A, et al. Deep brain stimulation for Parkinson’s disease: surgical technique and perioperative management. Mov Disord. 2006;21(Suppl 14):S247–58.
Bjartmarz H, Rehncrona S. Comparison of accuracy and precision between frame-based and frameless stereotactic navigation for deep brain stimulation electrode implantation. Stereotact Funct Neurosurg. 2007;85(5):235–42.
Bot M, et al. Analysis of stereotactic accuracy in patients undergoing deep brain stimulation using Nexframe and the Leksell frame. Stereotact Funct Neurosurg. 2015;93(5):316–25.
Henderson JM, et al. The application accuracy of a skull-mounted trajectory guide system for image-guided functional neurosurgery. Comput Aided Surg. 2004;9(4):155–60.
Cheng CY, et al. Deep brain stimulation for Parkinson’s disease using frameless technology. Br J Neurosurg. 2014;28(3):383–6.
Maciunas RJ, et al. An independent application accuracy evaluation of stereotactic frame systems. Stereotact Funct Neurosurg. 1992;58(1–4):103–7.
Hariz MI. Safety and risk of microelectrode recording in surgery for movement disorders. Stereotact Funct Neurosurg. 2002;78(3–4):146–57.
Kocabicak E, et al. Is there still need for microelectrode recording now the subthalamic nucleus can be well visualized with high field and ultrahigh MR imaging? Front Integr Neurosci. 2015;9:46.
Chen T, Mirzadeh Z, Ponce FA. “Asleep” deep brain stimulation surgery: a critical review of the literature. World Neurosurg. 2017;105:191–8.
Kochanski RB, Sani S. Awake versus asleep deep brain stimulation surgery: technical considerations and critical review of the literature. Brain Sci. 2018;8(1):pii: E17.
Chen T, et al. Clinical outcomes following awake and asleep deep brain stimulation for Parkinson disease. J Neurosurg. 2018;130(1):109–20. p. 1–12.
Schaltenbrand G, Walker AE. Stereotaxy of the human brain. New York: Thieme-Stratton; 1982.
Talairach J, Tournoux P. Co-planar stereotaxic atlas for the human brain: 3-D proportional system: an approach to cerebral imaging. New York: Thieme; 1988.
O’Gorman RL, et al. Optimal MRI methods for direct stereotactic targeting of the subthalamic nucleus and globus pallidus. Eur Radiol. 2011;21(1):130–6.
Vayssiere N, et al. Comparison of atlas- and magnetic resonance imaging-based stereotactic targeting of the globus pallidus internus in the performance of deep brain stimulation for treatment of dystonia. J Neurosurg. 2002;96(4):673–9.
Anderson WS, et al. Applying microelectrode recordings in neurosurgery. Contemp Neurosurg. 2010;32(3):1–7.
Anderson WS, Lenz FA. Surgery insight: deep brain stimulation for movement disorders. Nat Clin Pract Neuro. 2006;2(6):310–20.
Starr PA, et al. Microelectrode-guided implantation of deep brain stimulators into the globus pallidus internus for dystonia: techniques, electrode locations, and outcomes. Neurosurg Focus. 2004;17(1):E4.
Jitkritsadakul O, et al. Systematic review of hardware-related complications of deep brain stimulation: do new indications pose an increased risk? Brain Stimul. 2017;10(5):967–76.
Bruggemann N, et al. Short- and long-term outcome of chronic pallidal neurostimulation in monogenic isolated dystonia. Neurology. 2015;84(9):895–903.
Romito LM, et al. Pallidal stimulation for acquired dystonia due to cerebral palsy: beyond 5 years. Eur J Neurol. 2014;22(3):426–e32.
Beric A, et al. Complications of deep brain stimulation surgery. Stereotact Funct Neurosurg. 2001;77(1–4):73–8.
Burdick AP, et al. Relationship between higher rates of adverse events in deep brain stimulation using standardized prospective recording and patient outcomes. Neurosurg Focus. 2010;29(2):E4.
Chen T, et al. Complication rates, lengths of stay, and readmission rates in “awake” and “asleep” deep brain simulation. J Neurosurg. 2017;127(2):360–9.
Constantoyannis C, et al. Reducing hardware-related complications of deep brain stimulation. Can J Neurol Sci. 2005;32(2):194–200.
Fenoy AJ, Simpson RK Jr. Risks of common complications in deep brain stimulation surgery: management and avoidance. J Neurosurg. 2014;120(1):132–9.
Isaias IU, Alterman RL, Tagliati M. Deep brain stimulation for primary generalized dystonia: long-term outcomes. Arch Neurol. 2009;66(4):465–70.
Kaminska M, et al. Complications of Deep Brain Stimulation (DBS) for dystonia in children – the challenges and 10 year experience in a large paediatric cohort. Eur J Paediatr Neurol. 2017;21(1):168–75.
Patel DM, et al. Adverse events associated with deep brain stimulation for movement disorders: analysis of 510 consecutive cases. Neurosurgery. 2015;11(Suppl 2):190–9.
Sillay KA, Larson PS, Starr PA. Deep brain stimulator hardware-related infections: incidence and management in a large series. Neurosurgery. 2008;62(2):360–6. discussion 366-7
Zrinzo L, et al. Reducing hemorrhagic complications in functional neurosurgery: a large case series and systematic literature review. J Neurosurg. 2011;116(1):84–94.
Buhmann C, et al. Adverse events in deep brain stimulation: a retrospective long-term analysis of neurological, psychiatric and other occurrences. PLoS One. 2017;12(7):e0178984.
Gorgulho A, et al. Incidence of hemorrhage associated with electrophysiological studies performed using macroelectrodes and microelectrodes in functional neurosurgery. J Neurosurg. 2005;102(5):888–96.
Park CK, et al. Analysis of delayed intracerebral hemorrhage associated with deep brain stimulation surgery. World Neurosurg. 2017;104:537–44.
Binder DK, Rau GM, Starr PA. Risk factors for hemorrhage during microelectrode-guided deep brain stimulator implantation for movement disorders. Neurosurgery. 2005;56(4):722–32. discussion 722-32
Xiaowu H, et al. Risks of intracranial hemorrhage in patients with Parkinson’s disease receiving deep brain stimulation and ablation. Parkinsonism Relat Disord. 2010;16(2):96–100.
Umemura A, et al. Deep brain stimulation for movement disorders: morbidity and mortality in 109 patients. J Neurosurg. 2003;98(4):779–84.
Obeso JA, et al. Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson’s disease. N Engl J Med. 2001;345(13):956–63.
Allen NM, et al. Status dystonicus: a practice guide. Dev Med Child Neurol. 2014;56(2):105–12.
Termsarasab P, Frucht SJ. Dystonic storm: a practical clinical and video review. J Clin Mov Disord. 2017;4(10):10.
Cheung T, et al. Status dystonicus following deep brain stimulation surgery in DYT1 dystonia patients (P01.227). Neurology. 2012;78(1 Supplement):P01.227.
Kenney C, et al. Short-term and long-term safety of deep brain stimulation in the treatment of movement disorders. J Neurosurg. 2007;106(4):621–5.
Meoni S, et al. Pallidal deep brain stimulation for dystonia: a long term study. J Neurol Neurosurg Psychiatry. 2017;88(11):960–7.
Panov F, et al. Deep brain stimulation in DYT1 dystonia: a 10-year experience. Neurosurgery. 2013;73(1):86–93; discussion 93.
Sobstyl M, et al. Long-term outcomes of bilateral pallidal stimulation for primary generalised dystonia. Clin Neurol Neurosurg. 2014;126:82–7.
Tagliati M, et al. Long-term management of DBS in dystonia: response to stimulation, adverse events, battery changes, and special considerations. Mov Disord. 2011;26 Suppl 1(26):S54–62.
Piacentino M, Pilleri M, Bartolomei L. Hardware-related infections after deep brain stimulation surgery: review of incidence, severity and management in 212 single-center procedures in the first year after implantation. Acta Neurochir (Wien). 2011;153(12):2337–41.
Fenoy AJ, Simpson RK Jr. Management of device-related wound complications in deep brain stimulation surgery. J Neurosurg. 2012;116(6):1324–32.
Bhatia S, et al. Infections and hardware salvage after deep brain stimulation surgery: a single-center study and review of the literature. Stereotact Funct Neurosurg. 2010;88(3):147–55.
Fernandez FS, et al. Lead fractures in deep brain stimulation during long-term follow-up. Parkinsons Dis. 2009;2010(409356):409356.
Krauss JK, et al. Pallidal deep brain stimulation in patients with cervical dystonia and severe cervical dyskinesias with cervical myelopathy. J Neurol Neurosurg Psychiatry. 2002;72(2):249–56.
Yianni J, et al. Increased risk of lead fracture and migration in dystonia compared with other movement disorders following deep brain stimulation. J Clin Neurosci. 2004;11(3):243–5.
Jahanshahi M, Czernecki V, Zurowski AM. Neuropsychological, neuropsychiatric, and quality of life issues in DBS for dystonia. Mov Disord. 2011;26 Suppl 1(26):S63–78.
Halbig TD, et al. Pallidal stimulation in dystonia: effects on cognition, mood, and quality of life. J Neurol Neurosurg Psychiatry. 2005;76(12):1713–6.
de Gusmao CM, Pollak LE, Sharma N. Neuropsychological and psychiatric outcome of GPi-deep brain stimulation in dystonia. Brain Stimul. 2017;10(5):994–6.
Volkmann J, et al. Pallidal neurostimulation in patients with medication-refractory cervical dystonia: a randomised, sham-controlled trial. Lancet Neurol. 2014;13(9):875–84.
Schrader C, et al. GPi-DBS may induce a hypokinetic gait disorder with freezing of gait in patients with dystonia. Neurology. 2011;77(5):483–8.
Blahak C, et al. Micrographia induced by pallidal DBS for segmental dystonia: a subtle sign of hypokinesia? J Neural Transm (Vienna). 2011;118(4):549–53.
Berman BD, et al. Induction of bradykinesia with pallidal deep brain stimulation in patients with cranial-cervical dystonia. Stereotact Funct Neurosurg. 2009;87(1):37–44.
Huebl J, et al. Bradykinesia induced by frequency-specific pallidal stimulation in patients with cervical and segmental dystonia. Parkinsonism Relat Disord. 2015;21(7):800–3.
Yianni J, et al. Post-operative progress of dystonia patients following globus pallidus internus deep brain stimulation. Eur J Neurol. 2003;10(3):239–47.
Kupsch A, et al. The effects of frequency in pallidal deep brain stimulation for primary dystonia. J Neurol. 2003;250(10):1201–5.
Katayama Y, et al. Chronic stimulation of the globus pallidus internus for control of primary generalized dystonia. Acta Neurochir Suppl. 2003;87:125–8.
Coubes P, et al. Electrical stimulation of the globus pallidus internus in patients with primary generalized dystonia: long-term results. J Neurosurg. 2004;101(2):189–94.
Vayssiere N, et al. Deep brain stimulation for dystonia confirming a somatotopic organization in the globus pallidus internus. J Neurosurg. 2004;101(2):181–8.
Eltahawy HA, et al. Primary dystonia is more responsive than secondary dystonia to pallidal interventions: outcome after pallidotomy or pallidal deep brain stimulation. Neurosurgery. 2004;54(3):613–9; discussion 619–21.
Valldeoriola F, et al. Efficacy and safety of pallidal stimulation in primary dystonia: results of the Spanish multicentric study. J Neurol Neurosurg Psychiatry. 2010;81(1):65–9.
Vidailhet M, et al. Bilateral, pallidal, deep-brain stimulation in primary generalised dystonia: a prospective 3 year follow-up study. Lancet Neurol. 2007;6(3):223–9.
Loher TJ, et al. Deep brain stimulation for dystonia: outcome at long-term follow-up. J Neurol. 2008;255(6):881–4.
Volkmann J, et al. Pallidal deep brain stimulation in patients with primary generalised or segmental dystonia: 5-year follow-up of a randomised trial. Lancet Neurol. 2012;11(12):1029–38.
Cacciola F, et al. Bilateral deep brain stimulation for cervical dystonia: long-term outcome in a series of 10 patients. Neurosurgery. 2010;67(4):957–63.
Hung SW, et al. Long-term outcome of bilateral pallidal deep brain stimulation for primary cervical dystonia. Neurology. 2007;68(6):457–9.
Krauss JK, et al. Bilateral stimulation of globus pallidus internus for treatment of cervical dystonia. Lancet. 1999;354(9181):837–8.
Moro E, et al. Pallidal stimulation in cervical dystonia: clinical implications of acute changes in stimulation parameters. Eur J Neurol. 2009;16(4):506–12.
Yamada K, et al. Long disease duration interferes with therapeutic effect of globus pallidus internus pallidal stimulation in primary cervical dystonia. Neuromodulation. 2013;16(3):219–25; discussion 225.
Walsh RA, et al. Bilateral pallidal stimulation in cervical dystonia: blinded evidence of benefit beyond 5 years. Brain. 2013;136(Pt 3):761–9.
Inoue N, et al. Long-term suppression of Meige syndrome after pallidal stimulation: a 10-year follow-up study. Mov Disord. 2010;25(11):1756–8.
Sako W, et al. Bilateral pallidal deep brain stimulation in primary Meige syndrome. Parkinsonism Relat Disord. 2011;17(2):123–5.
Lyons MK, et al. Long-term follow-up of deep brain stimulation for Meige syndrome. Neurosurg Focus. 2010;29(2):E5.
Reese R, et al. Long-term clinical outcome in meige syndrome treated with internal pallidum deep brain stimulation. Mov Disord. 2011;26(4):691–8.
Ostrem JL, et al. Pallidal deep brain stimulation in patients with cranial-cervical dystonia (Meige syndrome). Mov Disord. 2007;22(13):1885–91.
Wang X, et al. Deep brain stimulation for Craniocervical dystonia (Meige syndrome): a report of four patients and a literature-based analysis of its treatment effects. Neuromodulation. 2016;19(8):818–23.
Vidailhet M, et al. Deep brain stimulation for dystonia. J Neurol Neurosurg Psychiatry. 2013;84(9):1029–42.
Chang EF, et al. Long-term benefit sustained after bilateral pallidal deep brain stimulation in patients with refractory tardive dystonia. Stereotact Funct Neurosurg. 2010;88(5):304–10.
Sako W, et al. Bilateral deep brain stimulation of the globus pallidus internus in tardive dystonia. Mov Disord. 2008;23(13):1929–31.
Trottenberg T, et al. Treatment of severe tardive dystonia with pallidal deep brain stimulation. Neurology. 2005;64(2):344–6.
Gruber D, et al. Long-term effects of pallidal deep brain stimulation in tardive dystonia. Neurology. 2009;73(1):53–8.
Capelle HH, et al. Chronic deep brain stimulation in patients with tardive dystonia without a history of major psychosis. Mov Disord. 2010;25(10):1477–81.
Spindler MA, et al. Globus pallidus interna deep brain stimulation for tardive dyskinesia: case report and review of the literature. Parkinsonism Relat Disord. 2013;19(2):141–7.
Marks WA, et al. Dystonia due to cerebral palsy responds to deep brain stimulation of the globus pallidus internus. Mov Disord. 2011;26(9):1748–51.
Vidailhet M, et al. Bilateral pallidal deep brain stimulation for the treatment of patients with dystonia-choreoathetosis cerebral palsy: a prospective pilot study. Lancet Neurol. 2009;8(8):709–17.
Gimeno H, et al. Beyond the Burke-Fahn-Marsden dystonia rating scale: deep brain stimulation in childhood secondary dystonia. Eur J Paediatr Neurol. 2012;16(5):501–8.
Koy A, et al. Effects of deep brain stimulation in dyskinetic cerebral palsy: a meta-analysis. Mov Disord. 2013;28(5):647–54.
Kupsch A, et al. Early postoperative management of DBS in dystonia: programming, response to stimulation, adverse events, medication changes, evaluations, and troubleshooting. Mov Disord. 2011;26 Suppl 1:S37–53.
Picillo M, et al. Programming deep brain stimulation for tremor and dystonia: the Toronto Western hospital algorithms. Brain Stimul. 2016;9(3):438–52.
Isaias IU, et al. Managing dystonia patients treated with deep brain stimulation. In Marks Jr. WJ, editor. Deep brain stimulation management. Cambridge University Press; 2015. p. 108–17.
Beaulieu-Boire I, Fasano A. Current or voltage? Another Shakespearean dilemma. Eur J Neurol. 2015;22(6):887–8.
Bronstein JM, et al. The rationale driving the evolution of deep brain stimulation to constant-current devices. Neuromodulation. 2015;18(2):85–8; discussion 88–9.
Pinsker MO, et al. Deep brain stimulation of the internal globus pallidus in dystonia: target localisation under general anaesthesia. Acta Neurochir (Wien). 2009;151(7):751–8.
Cheung T, et al. Defining a therapeutic target for pallidal deep brain stimulation for dystonia. Ann Neurol. 2014;76(1):22–30.
Hamani C, et al. Location of active contacts in patients with primary dystonia treated with globus pallidus deep brain stimulation. Neurosurgery. 2008;62(3 Suppl 1):217–23; discussion 223–5.
Coubes P, et al. Electrical stimulation of the globus pallidus internus in patients with primary generalized dystonia: long-term results. Journal of neurosurgery. 2004;101(2):189–94.
Vercueil L, et al. Effects of pulse width variations in pallidal stimulation for primary generalized dystonia. J Neurol. 2007;254(11):1533–7.
Bereznai B, et al. Chronic high-frequency globus pallidus internus stimulation in different types of dystonia: a clinical, video, and MRI report of six patients presenting with segmental, cervical, and generalized dystonia. Mov Disord. 2002;17(1):138–44.
Liu LD, et al. Frequency-dependent effects of electrical stimulation in the globus pallidus of dystonia patients. J Neurophysiol. 2012;108(1):5–17.
Almeida L, et al. A pilot trial of square biphasic pulse deep brain stimulation for dystonia: the BIP dystonia study. Mov Disord. 2017;32(4):615–8.
Cagnan H, et al. Stimulating at the right time: phase-specific deep brain stimulation. Brain. 2017;140(1):132–45.
Bologna M, Berardelli A. Cerebellum: an explanation for dystonia? Cerebellum Ataxias. 2017;4:6.
Calderon DP, et al. The neural substrates of rapid-onset Dystonia-Parkinsonism. Nat Neurosci. 2011;14(3):357–65.
Chen CH, et al. Short latency cerebellar modulation of the basal ganglia. Nat Neurosci. 2014;17(12):1767–75.
Shakkottai VG, et al. Current opinions and areas of consensus on the role of the cerebellum in dystonia. Cerebellum. 2017;16(2):577–94.
Shaikh AG, et al. Cervical dystonia: a neural integrator disorder. Brain. 2016;139(Pt 10):2590–9.
Bertrand C, et al. Technical aspects of selective peripheral denervation for spasmodic torticollis. Appl Neurophysiol. 1982;45:326–30.
Bertrand C, et al. Selective peripheral denervation in 111 cases of spasmodic torticollis: rationale and results. Adv Neurol. 1988;50:637–43.
Anderson WS, et al. Selective denervation of the levator scapulae muscle: an amendment to the Bertrand procedure for the treatment of spasmodic torticollis. J Neurosurg. 2008;108(4):757.
Ford B, et al. Outcome of selective ramisectomy for botulinum toxin resistant torticollis. J Neurol Neurosurg Psychiatry. 1998;65(4):472–8.
Münchau A, et al. Prospective study of selective peripheral denervation for botulinum-toxin resistant patients with cervical dystonia. Brain. 2001;124(4):769–83.
Cohen-Gadol AA, et al. Selective peripheral denervation for the treatment of intractable spasmodic torticollis: experience with 168 patients at the Mayo Clinic. J Neurosurg. 2003;98(6):1247–54.
Bergenheim AT, et al. Selective peripheral denervation for cervical dystonia: long-term follow-up. J Neurol Neurosurg Psychiatry. 2015;86(12):1307–13.
Contarino MF, et al. Selective peripheral denervation: comparison with pallidal stimulation and literature review. J Neurol. 2014;261(2):300–8.
Meyer CH. Outcome of selective peripheral denervation for cervical dystonia. Stereotact Funct Neurosurg. 2001;77(1–4):44–7.
Braun V, Richter HP. Selective peripheral denervation for spasmodic torticollis: 13-year experience with 155 patients. J Neurosurg. 2002;97(2 Suppl):207–12.
Ravindran K, et al. Deep brain stimulation versus peripheral denervation for cervical dystonia: a systematic review and meta-analysis. World Neurosurg. 2018;122:e940–6.
Laitinen LV. Leksell’s unpublished pallidotomies of 1958-1962. Stereotact Funct Neurosurg. 2000;74(1):1–10.
Steiner L, et al. Gammathalamotomy in intractable pain. Acta Neurochir (Wien). 1980;52(3–4):173–84.
Iacono RP, et al. Simultaneous bilateral pallidoansotomy for idiopathic dystonia musculorum deformans. Pediatric Neurology. 1996;14(2):145–8.
Lozano AM, et al. Globus pallidus internus pallidotomy for generalized dystonia. Movement Disorders. 1997;12(6):865–70.
Gross RE. What happened to posteroventral pallidotomy for Parkinson’s disease and dystonia? Neurotherapeutics. 2008;5(2):281–93.
Teive HAG, et al. Bilateral pallidotomy for generalized dystonia. Arquivos de Neuro-Psiquiatria. 2001;59:353–7.
Ondo WG, et al. Pallidotomy for generalized dystonia. Movement Disorders. 1998;13(4):693–8.
Takeda N, et al. Radiofrequency lesioning through deep brain stimulation electrodes in patients with generalized dystonia. World Neurosurg. 2018;115:220–4.
Frighetto L, et al. Stereotactic radiosurgery for movement disorders. Surg Neurol Int. 2012;3(Suppl 1):S10–6.
Kondziolka D, Flickinger JC, Lunsford LD. Stereotactic radiosurgery for epilepsy and functional disorders. Neurosurg Clin N Am. 2013;24(4):623–32.
Niranjan A, et al. Stereotactic radiosurgery for essential tremor: retrospective analysis of a 19-year experience. Mov Disord. 2017;32(5):769–77.
Gross RE, Stern MA. Magnetic resonance-guided stereotactic laser pallidotomy for dystonia. Mov Disord. 2018;33:1502.
Elias WJ, et al. A randomized trial of focused ultrasound Thalamotomy for essential tremor. N Engl J Med. 2016;375(8):730–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Wojtasiewicz, T., Butala, A., Anderson, W.S. (2020). Dystonia. In: Pouratian, N., Sheth, S. (eds) Stereotactic and Functional Neurosurgery. Springer, Cham. https://doi.org/10.1007/978-3-030-34906-6_22
Download citation
DOI: https://doi.org/10.1007/978-3-030-34906-6_22
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-34905-9
Online ISBN: 978-3-030-34906-6
eBook Packages: MedicineMedicine (R0)